Pericardial effusion leading to acute renal failure: Two case reports and discussion of pathophysiology

2002 ◽  
Vol 40 (4) ◽  
pp. 837-841 ◽  
Author(s):  
Mohammad Saklayen ◽  
Vijay V. Anne ◽  
Miguel Lapuz
2011 ◽  
Vol 50 (7) ◽  
pp. 719-721 ◽  
Author(s):  
Nathan Gluck ◽  
Mordechai Fried ◽  
Reuven Porat

2006 ◽  
Vol 116 (3) ◽  
pp. 165-172 ◽  
Author(s):  
Dirk Henrich ◽  
Martin Hoffmann ◽  
Michael Uppenkamp ◽  
Raoul Bergner

Author(s):  
Nihat M Hokenek ◽  
Mehmet O Erdogan ◽  
Davut Tekyol ◽  
Hakan Hançer ◽  
Ergul A Kozan ◽  
...  

Pericardial effusion secondary to contrast nephropathy is a very rare clinical condition. Patients have a volume load increase secondary to acute renal failure. In such a case, the progression of pericardial effusion with tamponade may follow a very rapid course contrary to what is believed. In this case, a 78-year-old male patient with diabetes mellitus and hypertension was admitted to the emergency department with complaints of decreased urine output, nausea, and vomiting. The patient was diagnosed with acute renal failure secondary to contrast nephropathy. Pericardial effusion amount was found to be 2 cm by thorax tomography. As the patient who had no urine output when his vital signs were stable became unstable during dialysis preparation and manifested clinical symptoms of cardiac tamponade, immediate pericardiocentesis was performed. Following that, he became stable and was transferred to the intensive care unit. In current guidelines regarding indications for pericardiocentesis, it is stated that drainage should be performed when the amount of effusion is more than 2 cm in the absence of tamponade, suspected bacterial infection or neoplastic etiology. However, in contrast to the standard approach to patients with acute renal failure, our suggestion is that the indications for pericardiocentesis may be broader in the presence of pericardial effusion.


2018 ◽  
Vol 7 (2) ◽  
pp. 33-38
Author(s):  
Emrah Bozbeyoğlu ◽  
Özlem Yıldırımtürk ◽  
Yiğit Çanga ◽  
Mert İlker Hayıroğlu ◽  
Ayça Gümüşdağ ◽  
...  

2020 ◽  
Vol 2020 ◽  
pp. 1-6
Author(s):  
Gisela Marcelino ◽  
Ould Maouloud Hemett ◽  
Eric Descombes

Direct oral anticoagulants (DOACs) are among the most commonly prescribed medications, and DOAC-associated kidney dysfunction may be a problem that is underrecognized by clinicians. We report on the case of an 82-year-old patient who, two weeks after the prescription of rivaroxaban for atrial fibrillation, was hospitalized for a drug-induced hypersensitivity syndrome whose main clinical manifestations were low-grade fever with a petechial rash in the legs and acute renal failure (ARF). Within one week after rivaroxaban withdrawal, the patient’s clinical condition improved and the renal function normalized. In a review of the literature, we only found five case reports of rivaroxaban-related ARF: two patients had tubulo-interstitial nephritis (TIN), two had anticoagulant-related nephropathy (ARN), and the last one had IgA nephropathy. As some recent publications suggest that kidney injury due to anticoagulation drugs may be largely underdiagnosed, we also analyzed the data from the VigiAccess database, the World Health Organization pharmacovigilance program that collects drug-related adverse events from 134 national registries worldwide. Among all the rivaroxaban-associated adverse events reported in VigiAccess since 2006, 4,323 (3.5%) were renal side effects, of which 2,351 (54.3%) were due to unspecified ARF, 363 (8.4%) were due to renal hemorrhage (characteristically associated with ARN), and 24 (0.6%) were due to TIN. We also compared these results with those reported in VigiAccess for other DOACs and vitamin K antagonists. This analysis suggests that the frequency of renal adverse events associated with rivaroxaban and other DOACs may be appreciably higher than what one might currently consider based only on the small number of fully published cases.


2019 ◽  
Vol 2019 ◽  
pp. 1-5
Author(s):  
D. Kelsey ◽  
A. J. Berry ◽  
R. A. Swain ◽  
S. Lorenz

Energy drinks are nonalcoholic beverages that are widely consumed in the general population, and worldwide usage is increasing. The main stimulant component of energy drinks is typically caffeine. Few case reports exist that link energy drink consumption to psychosis, and similarly few reports exist that associate energy drink consumption with acute renal failure. We present a patient who simultaneously developed psychosis and acute renal failure associated with excessive energy drink consumption. The patient required haemodialysis, and his psychosis resolved on cessation of energy drinks and a brief course of antipsychotic medication. We perform a review of similar cases where excessive caffeinated energy drink consumption has been linked to psychosis or acute renal failure. To our knowledge, this is the first case report describing both renal failure and psychosis occurring simultaneously in a patient. Recognising the spectrum of disorders associated with excessive energy drink consumption is vital for both physicians and psychiatrists, as this has important implications for both prognosis and treatment.


2015 ◽  
Vol 8 (1) ◽  
Author(s):  
Ranga Migara Weerakkody ◽  
Pushpa Nandani Lokuliyana ◽  
Mohammed Hussain Rezvi Sheriff

2013 ◽  
Vol 31 (8) ◽  
pp. 1283-1284 ◽  
Author(s):  
Alfredo De Giorgi ◽  
Fabio Fabbian ◽  
Giulia Piazza ◽  
Ambra Faccini ◽  
Alessandra Mallozzi Menegatti ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document